A single nucleotide polymorphism in OPRM1(rs483481) and risk for heroin use disorder

References

• Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci. 2005;8(11):1450–7. doi:10.1038/nn1583.
   PubMed Web of Science ®Google Scholar
• Piestrzeniewicz MK, Fichna J, Michna J, Janecka A. Opioid receptors and their selective ligands. Postepy Biochem. 2006;52(3):313–9.
   PubMedGoogle Scholar
• Levran O, Yuferov V, Kreek MJ. The genetics of the opioid system and specific drug addictions. Hum Genet. 2012;131(6):823–42. doi:10.1007/s00439-012-1172-4.
   PubMed Web of Science ®Google Scholar
• Mague SD, Blendy JA. OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models. Drug Alcohol Depend. 2010;108(3):172–82. doi:10.1016/j.drugalcdep.2009.12.016.
   PubMed Web of Science ®Google Scholar
• Tan EC, Lim EC, Teo YY, Lim Y, Law HY, Sia AT. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain. 2009;5:1744-8069-5-32. doi:10.1186/1744-8069-5-32.
   Web of Science ®Google Scholar
• https://www.ncbi.nlm.nih.gov/gene/4988.
   Google Scholar
• Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HWD, Koob GF. μ-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther. 2000;293(3):1002–8.
   PubMed Web of Science ®Google Scholar
• Shen X, Purser C, Tien L-T, Chiu C-T, Paul IA, Baker R, Loh HH, Ho IK, Ma T. μ-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res. 2010;88(10):2294–302. doi:10.1002/jnr.22386.
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. Drugs, brains and behavior. The science of addiction. 2010. NIH Publication No. 10-5605. Bethesda: National Institute of Health.
   Google Scholar
• Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP, Hulse GK, Wildenauer D, Kelty EA, Schwab SG, et al. Cis-Expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1. Biol Psychiatry. 2015;78(7):474–84. doi:10.1016/j.biopsych.2015.01.003.
   PubMed Web of Science ®Google Scholar
• Zhang D, Shao C, Shao M, Yan P, Wang Y, Liu Y, Liu W, Lin T, Xie Y, Zhao Y, et al. Effect of μ-Opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry. 2007;61(11):1244–51. doi:10.1016/j.biopsych.2006.07.012.
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Ji F, Yuferov V, Ho A, Chen A, Levran O, Ott J, Kreek MJ. Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry. 2008;13(4):417–28. doi:10.1038/sj.mp.4002147.
   PubMed Web of Science ®Google Scholar
• Kraus J, Börner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, König W, Höllt V, et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem. 2001;276(47):43901–8. doi:10.1074/jbc.M107543200.
   PubMed Web of Science ®Google Scholar
• Kraus J, Borner C, Giannini E, Hollt V. The role of nuclear factor kappaB in tumor necrosis factor regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol. 2003;64(4):876–84. doi:10.1124/mol.64.4.876.
   PubMed Web of Science ®Google Scholar
• Beyer A, Koch T, Schroder H, Schulz S, Hollt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem. 2004;89(3):553–60. doi:10.1111/j.1471-4159.2004.02340.x.
   PubMed Web of Science ®Google Scholar
• Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet. 2000;9(19):2895–908. doi:10.1093/hmg/9.19.2895.
   PubMed Web of Science ®Google Scholar
• Luo X, Kranzler HR, Zhao H, Gelernter J. Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Genet. 2003; 120:97–108. doi:10.1002/ajmg.b.20034.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16(3):1215. doi:10.1093/nar/16.3.1215.
   PubMed Web of Science ®Google Scholar
• Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007;23(10):1289–91. doi:10.1093/bioinformatics/btm091.
   PubMed Web of Science ®Google Scholar
• Yeh FC, Yang RC, Boyle TB, Ye Z, Mao JX. POPGENE, the user-friendly shareware for population genetic analysis. Canada: Molecular Biology and Biotechnology Centre, University of Alberta; 1997: 10.
   Google Scholar
• Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008;66(2):87–98. doi:10.1159/000119108.
   PubMed Web of Science ®Google Scholar
• http://www.hutchon.net/confidornulhypo.htm. (Last accessed: 4.10 2018).
   Google Scholar
• Barret JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–65. doi:10.1093/bioinformatics/bth457.
   PubMed Web of Science ®Google Scholar
• Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376–82. doi:10.1093/bioinformatics/btf869.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368. doi:10.1093/nar/gkw937.
   PubMed Web of Science ®Google Scholar
• McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, Flicek P, Cunningham F. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122. doi:10.1186/s13059-016-0974-4.
   PubMed Web of Science ®Google Scholar
• Maher BS, Vladimirov VI, Latendresse SJ, Thiselton DL, McNamee R, Kang M, Bigdeli TB, Chen X, Riley BP, Hettema JM, et al. The AVPR1A Gene and Substance Use Disorders: Association, Replication, and Functional Evidence. Biol. Psychiatry. 2011;70(6):519–27. doi:10.1016/j.biopsych.2011.02.023.
   PubMed Web of Science ®Google Scholar
• Xu J, Lu Z, Xu M, Pan L, Deng Y, Xie X, Liu H, Ding S, Hurd YL, Pasternak GW, et al. A Heroin Addiction Severity-Associated Intronic Single Nucleotide Polymorphism Modulates Alternative Pre-mRNA Splicing of theµ-Opioid Receptor Gene OPRM1 via hnRNPH Interactions. J. Neurosci. 2014;34(33):11048–66. doi:10.1523/JNEUROSCI.3986-13.2014.
   PubMed Web of Science ®Google Scholar
• Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, et al. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. Am J Psychiatry. 2010;167(5):65–573. doi:10.1176/appi.ajp.2009.08081167.
   Web of Science ®Google Scholar
• Xuei X, Flury‐Wetherill L, Bierut L, Dick D, Nurnberger J, Foroud T, Edenberg HJ. The opioid system in alcohol and drug dependence: Family-Based association study. Am J Med Genet . 2007;144B(7):877–84. doi:10.1002/ajmg.b.30531.
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN, Jaradat SA, Su SY, Tay GK, Hulse GK. Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent. Pharmgenomics Pers Med. 2012;5:99–111. doi:10.2147/PGPM.S33351.
   PubMedGoogle Scholar
• Corley RP, Zeiger JS, Crowley T, Ehringer MA, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH, Smolen A, et al. Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend. 2008;96(1-2):90–98. doi:10.1016/j.drugalcdep.2008.02.004.
   PubMed Web of Science ®Google Scholar
• Randesi M, Levran O, Butelman E, Yuferov V, Ott J, Blanken P, et al. Gene variants of the opioid system – Relationship to heroin self-exposure, addiction, and treatment. Drug Alcohol Depend. 2015;146:e34–e117.
   Google Scholar
• Clarke T-K, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O’Brien CP, Oslin DW, Lohoff FW, et al. Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav. 2012;11(4):415–423. doi:10.1111/j.1601-183X.2012.00785.x.
   PubMed Web of Science ®Google Scholar
• Okahisa Y, Kodama M, Takaki M, Inada T, Uchimura N, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, et al. Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence. CN. 2011;9(1):183–189. doi:10.2174/157015911795017191.
   Google Scholar
• Kest B, Smith SB, Schorscher-Petcu A, Austin J-S, Ritchie J, Klein G, Rossi GC, Fortin A, Mogil JS. Gnao1 (Gαo protein) is a likely genetic contributor to variation in physical dependence on opioids in mice. Neuroscience. 2009;162(4):1255–1264. doi:10.1016/j.neuroscience.2009.05.027.
   PubMed Web of Science ®Google Scholar
• Yuferov V, Levran O, Proudnikov D, Nielsen DA, Kreek MJ. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction, and treatment. Ann N Y Acad Sci. 2010;1187(1):184–207. doi:10.1111/j.1749-6632.2009.05275.x.
   PubMedGoogle Scholar
• Haerian BS, Haerian MS. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics. 2013;14(7):813–824. doi:10.2217/pgs.13.57.
   PubMed Web of Science ®Google Scholar
• Gretton SK, Droney J. Splice variation of the mu-opioid receptor and its effect on the action of opioids. Br J Pain. 2014;8(4):133–138. doi:10.1177/2049463714547115.
   PubMedGoogle Scholar